Seagen Inc. Insider Trading for December 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for December 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 16.41 | 3,100 | 50,871 | 5,024 | |
| Dec 20 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 16.41 | 3,100 | 50,871 | 61,604 | 58.5 K to 61.6 K (+5.30 %) |
| Dec 15 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 26.10 | 10,000 | 261,000 | 926 | |
| Dec 15 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 18.46 | 2,761 | 50,968 | 0 | |
| Dec 15 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 64.35 | 1,194 | 76,833 | 58,504 | 59.7 K to 58.5 K (-2.00 %) |
| Dec 15 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 18.46 | 2,761 | 50,968 | 59,698 | 56.9 K to 59.7 K (+4.85 %) |
| Dec 15 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 63.25 | 8,806 | 557,002 | 56,937 | 65.7 K to 56.9 K (-13.39 %) |
| Dec 15 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 26.10 | 10,000 | 261,000 | 65,743 | 55.7 K to 65.7 K (+17.94 %) |
| Dec 14 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 26.10 | 3,831 | 99,989 | 0 | |
| Dec 14 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 15.46 | 6,468 | 99,995 | 0 | |
| Dec 14 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 12.00 | 5,333 | 63,996 | 0 | |
| Dec 14 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 12.00 | 5,333 | 63,996 | 151,011 | 145.7 K to 151 K (+3.66 %) |
| Dec 14 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 15.46 | 6,468 | 99,995 | 145,678 | 139.2 K to 145.7 K (+4.65 %) |
| Dec 14 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 26.10 | 3,831 | 99,989 | 139,210 | 135.4 K to 139.2 K (+2.83 %) |
| Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 9,700 | 199,044 | 0 | |
| Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 2,800 | 57,456 | 9,700 | |
| Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 65.90 | 9,700 | 639,234 | 87,767 | 97.5 K to 87.8 K (-9.95 %) |
| Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 9,700 | 199,044 | 97,467 | 87.8 K to 97.5 K (+11.05 %) |
| Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 66.00 | 2,800 | 184,808 | 87,767 | 90.6 K to 87.8 K (-3.09 %) |
| Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 2,800 | 57,456 | 90,567 | 87.8 K to 90.6 K (+3.19 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 9.23 | 30,000 | 276,900 | 23,164 | |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 66.08 | 1,427 | 94,301 | 135,379 | 136.8 K to 135.4 K (-1.04 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 65.29 | 28,573 | 1,865,443 | 136,806 | 165.4 K to 136.8 K (-17.28 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 9.23 | 30,000 | 276,900 | 165,379 | 135.4 K to 165.4 K (+22.16 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 10,423 | 107,253 | 83,374 | |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,042 | 41,228 | 20,207 | |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 65.70 | 4,042 | 265,577 | 638,835 | 642.9 K to 638.8 K (-0.63 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,042 | 41,228 | 642,877 | 638.8 K to 642.9 K (+0.63 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 66.35 | 10,423 | 691,568 | 638,835 | 649.3 K to 638.8 K (-1.61 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 10,423 | 107,253 | 649,258 | 638.8 K to 649.3 K (+1.63 %) |